최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기소아감염 = Korean journal of pediatric infectious diseases, v.17 no.2, 2010년, pp.156 - 168
김창휘 (순천향대학교 부천병원 소아청소년과) , 차성호 (경희대학교병원 소아청소년과) , 신손문 (제일병원 소아청소년과) , 김천수 (계명대학교 동산의료원 소아청소년과) , 최영륜 (전남대학교병원 소아청소년과) , 홍영진 (인하대병원소아청소년과) , 최명재 (인제대학교 상계백병원 소아청소년과) , 김광남 (한림대학교 한강성심병원 소아청소년과) , 허재균 (가톨릭대학교 성바오로병원 소아청소년과) , 조대선 (전북대학교병원 소아청소년과) , 김성신 (순천향대학교 부천병원 소아청소년과) , 이상락 (계명대학교 동산의료원 소아청소년과) , 송은송 (전남대학교병원 소아청소년과) , , 옥진주 , , , 김정수 (전북대학교병원 소아청소년과)
Purpose : To compare immunogenicity and reactogenicity of a combined diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine (DTPa-IPV,
World Health Organization (WHO). Immunization surveillance, assessment and monitoring. Immunization Profile - Republic of Korea [Internet]. [updated 10 Aug 2009; cited 2010 Feb 4]. Available from: http://www.who.int/immunization_monitoring/en/globalsummary/countryprofileresult.cfm?C'kor'
The Korean Pediatric Society. DTaP and Td vaccines. In: Lee HJ, editors. Immunization Guideline. 6th edition. Seoul: The Korean Pediatric Society, 2008.
Kim HH, Shin KH, Kim SN, Lee MS, Yoo SH, Kim JY, et al. Investigation on the immunity to pertussis in Korea. J Korean Soc Microbiol 1999;34:583-9.
Shek LP, Khor ES, Tan GH, Low KT, Ong D, Roy J, et al. Comparative study of the reactogenicity of a threecomponent acellular pertussis vaccine and whole-cell pertussis vaccine administered to healthy Singaporean infants. Southeast Asian J Trop Med Public Health 2003; 34:863-8.
Jefferson T, Rudin M, DiPietrantonj C. Systematic review of the effects of pertussis vaccines in children. Vaccine 2003;21:2003-14.
Division of Vaccine Preventable Disease Control and National Immunization Program. Korea Centers for Disease Control and Prevention Monthly Newsletter 2007;5:28.
Korea Centers for Disease Control and Prevention [Internet]. [cited 2009 Oct 15]. Available from: http://www.cdc.go.kr
Yoo S, Ahn KO, Park EH, Cho HS, Park CY, Lee HR. Epidemiologic and clinical features of pertussis in children (2000.3-2001.3). J Korean Pediatr Soc 2002;45:603-8.
Kim SJ, Kim SH, Jee YM, Kim JS. Vaccine-associated paralytic poliomyelitis: a case report of flaccid monoparesis after oral polio vaccine. J Korean Med Sci 2007; 22:362-4.
World Health Organization (WHO). Major milestone reached in global polio eradication: Western Pacific region is certified polio-free. Press release WHO/71 29 October 2000 [Internet]. Accessed 01-09-2008. Available from: https://www.who.int/inf-pr-2000/en/pr2000-71.html
Happe LE, Lunacsek OE, Marshall GS, Lewis T, Spencer S. Combination vaccine use and vaccination quality in a managed care population. Am J Manag Care 2007; 13:506-12.
Kalies H, Grote V, Verstraeten T, Hessel L, Schmitt HJ, von Kries R. The use of combination vaccines has improved timeliness of vaccination in children. Pediatr Infect Dis J 2006;25:507-12.
Schmitt HJ, von Konig CH, Neiss A, Bogaerts H, Bock HL, Schulte-Wissermann H, et al. Efficacy of acellular pertussis vaccine in early childhood after household exposure. JAMA 1996;275:37-41.
Greco D, Salmaso S, Mastrantonio P, Giuliano M, Tozzi AE, Anemona A, et al. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. N Engl J Med 1996;334:341-8.
Camargo ME, Silveira L, Furuta JA, Oliveira EP, Germek OA. Immunoenzymatic assay of anti-diphtheric toxin antibodies in human serum. J Clin Microbiol 1984;20: 772-4.
Melville-Smith ME, Seagroatt VA, Watkins JT. A comparison of enzyme-linked immunosorbent assay (ELISA) with the toxin neutralization test in mice as a method for the estimation of tetanus antitoxin in human sera. J Biol Stand 1983;11:137-44.
Schmitt HJ, Knuf M, Ortiz E, Sanger R, Uwamwezi MC, Kaufhold A. Primary vaccination of infants with diphtheria- tetanus-acellular pertussis-hepatitis B virus-inactivated polio virus and Haemophilus influenzae type b vaccines given as either separate or mixed injections. J Pediatr 2000;137:304-12.
World Health Organization (WHO). Standard procedure for determining immunity to poliovirus using the microneutralization test. 1993. WHO/EPI/Gen 93
20) Black S, Friedland LR, Schuind A, Howe B; GlaxoSmith- Kline DTaP-IPV Vaccine Study Group. Immunogenicity and safety of a combined DTaP-IPV vaccine compared with separate DTaP and IPV vaccines when administered as pre-school booster doses with a second dose of MMR vaccine to healthy children aged 4-6 years. Vaccine 2006;24:6163-71.
Black S, Friedland LR, Ensor K, Weston WM, Howe B, Klein NP. Diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines given separately or combined for booster dosing at 4-6 years of age. Pediatr Infect Dis J 2008;27:341-6.
Marshall H, Nolan T, Roberton D, Richmond P, Lambert S, Jacquet JM, et al. A comparison of booster immunisation with a combination DTPa-IPV vaccine or DTPa plus IPV in separate injections when co-administered with MMR, at age 4-6 years. Vaccine 2006;24: 6120-8.
Jacquet JM, Begue P, Grimprel E, Reinert P, Sandbu S, Silfverdal SA, et al. Safety and immunogenicity of a combined DTPa-IPV vaccine administered as a booster from 4 years of age: A review. Vaccine 2006;24:2440-8.
Nilsson L, Faldella G, Jacquet JM, Storsaeter J, Silfverdal SA, Ekholm L. A fourth dose of DTPa-IPV vaccine given to 4-6 year old children in Italy and Sweden following primary vaccination at 3, 5 and 11-12 months of age. Scand J Infect Dis 2005;37:221-29.
Lin TY, Wang YH, Chang LY, Chui CH, Huang YC, Tang H, et al. Safety and immunogenicity of a diphtheria, tetanus and acellular-pertussis-inactivated poliovirus vaccine/Heamophilus influenza type b combination vaccine administered to Taiwanese infants at 2, 4 and 6 months of age. Chang Gung Med J 2003;26:315-22.
Begue PC, Grimprel EM, Giovannangeli MD, Abitbol VI. Comparative reactogenicity and immunogenicity of booster doses of diphtheria-tetanus-acellular pertussisinactivated poliovirus vaccine and diphtheria-tetanusinactivated poliovirus vaccine in preadolescents. Pediatr Infect Dis J 1998;17:804-9.
Pace D, Snape M, Westcar S, Hamaluba M, Yu LM, Begg N, et al. A new combination Haemophilus influenzae type B and Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine for primary immunization of infants. Pediatr Infect Dis J 2007;26:1057-9.
Immunisation Advisory Centre. Introducing Infanrix $^{\circledR}$ - hexa fact sheet for parents and caregivers. Available from: www.immune.org.nz
Weston WM, Klein NP. Kinrix: a new combination DTaP-IPV vaccine for children aged 4-6 years. Expert Rev Vaccines 2008;7:1309-20.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
저자가 공개 리포지터리에 출판본, post-print, 또는 pre-print를 셀프 아카이빙 하여 자유로운 이용이 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.